SCHEMBL16611699

SCHEMBL16611699

CCSc1ccncc1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.49
ALDH1A1 P00352 2/20 0.47
KDM4C Q9H3R0 9/20 0.46
KDM6B O15054 5/20 0.46
TDP1 Q9NUW8 2/20 0.44
KDM4E B2RXH2 2/20 0.44
KDM4A O75164 2/20 0.44
KDM4D Q6B0I6 2/20 0.44
MEN1 O00255 1/20 0.44
MAPT P10636 1/20 0.44
THRB P10828 1/20 0.44
KMT2A Q03164 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
SLC22A12 Q96S37 6/20 0.40
SIRT3 Q9NTG7 1/20 0.40
CYP1A2 P05177 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16612069 0.98 HSD17B10 (0.48) HSD17B10ALDH1A1KDM4CKDM6BTDP1
SCHEMBL1023957 0.86 KDM4C (0.50) HSD17B10ALDH1A1KDM4CKDM6BTDP1
SCHEMBL1328542 0.85 SIRT3 (0.54) HSD17B10ALDH1A1KDM4CKDM6BTDP1
SCHEMBL9705216 0.85 HSD17B10 (0.48) HSD17B10ALDH1A1KDM4CKDM6BTDP1
SCHEMBL3074800 0.80 KDM4C (0.49) HSD17B10ALDH1A1KDM4CKDM6BTDP1
SCHEMBL7919 0.80 SLC22A12 (0.56) ALDH1A1KDM4CKDM6BTDP1KDM4E
SCHEMBL4018089 0.80 CA12 (0.48) HSD17B10ALDH1A1KDM4CKDM6BTDP1
SCHEMBL1656950 0.80 POLB (0.52) ALDH1A1KDM4CKDM6BTDP1KDM4E
SCHEMBL10469069 0.79 CA12 (0.57) ALDH1A1KDM4CKDM6BKDM4EKDM4A
SCHEMBL17824488 0.79 KDM4C (0.40) HSD17B10ALDH1A1KDM4CKDM6BTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2857397-B1 FUSED HETEROCYCLIC COMPOUND SUMITOMO CHEMICAL CO (JP) 2020-04-08 EP disclosed
US-9364000-B2 Method of controlling pests with fused heterocyclic compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-06-14 US disclosed
US-9364000-B2 Method of controlling pests with fused heterocyclic compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-06-14 US disclosed
US-9364000-B2 Method of controlling pests with fused heterocyclic compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-06-14 US disclosed
US-20150373982-A1 METHOD OF CONTROLLING PESTS WITH FUSED HETEROCYCLIC COMPOUND SUMITOMO CHEMICAL CO (JP) 2015-12-31 US disclosed
US-20150373982-A1 METHOD OF CONTROLLING PESTS WITH FUSED HETEROCYCLIC COMPOUND SUMITOMO CHEMICAL CO (JP) 2015-12-31 US disclosed
US-20150373982-A1 METHOD OF CONTROLLING PESTS WITH FUSED HETEROCYCLIC COMPOUND SUMITOMO CHEMICAL CO (JP) 2015-12-31 US disclosed
US-20150166573-A1 FUSED HETEROCYCLIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-06-18 US disclosed
US-20150166573-A1 FUSED HETEROCYCLIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-06-18 US disclosed
US-20150166573-A1 FUSED HETEROCYCLIC COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-06-18 US disclosed
EP-2857397-A1 FUSED HETEROCYCLIC COMPOUND Sumitomo Chemical Company Limited (JP) 2015-04-08 EP disclosed
EP-2857397-A1 FUSED HETEROCYCLIC COMPOUND Sumitomo Chemical Company Limited (JP) 2015-04-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150373982-A1 METHOD OF CONTROLLING PESTS WITH FUSED HETEROCYCLIC COMPOUND NR4A1, NR2E1, NR0B1 HSD17B10 1418/4885ALDH1A1 2552/4885KDM4C 1351/4885
US-20150166573-A1 FUSED HETEROCYCLIC COMPOUND NR4A1, NR2E1, NR0B2 HSD17B10 1528/4885ALDH1A1 2594/4885KDM4C 1474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.